Pharmacokinetics and immunogenicity of T0001, a newly developed anti-TNFα fusion protein, in healthy volunteers

Pharmacokinetics and immunogenicity of T0001, a newly developed anti-TNFα fusion protein, in... Eur J Clin Pharmacol (2017) 73:1095–1101 DOI 10.1007/s00228-017-2280-9 CLINICAL TRIAL Pharmacokinetics and immunogenicity of T0001, a newly developed anti-TNFα fusion protein, in healthy volunteers 1,2 1,3 4 5 6 1 Yitong Wang & Chang Liu & Shi Chen & Wei Wang & Lihou Dong & Qian Wang & 1 7 8 9 1,2 10 Yan Wang & Libo Zhao & Yannan Zang & Zhenwei Xie & Yang Liu & Yanjun Liu & 6 4 1 Haifeng Song & Zhanguo Li & Yi Fang Received: 6 April 2017 /Accepted: 2 June 2017 /Published online: 21 June 2017 Springer-Verlag GmbH Germany 2017 Abstract dose–exposure proportionality analysis, the estimated points Purpose T0001 was the first mutant of recombinant fusion for AUC and C were 0.87 with a 90% CI of 0.76–0.98 0-∞ max protein of human tumor necrosis factor receptor and Fc frag- and 0.86 with a 90% CI of 0.74–0.97 respectively. The plasma ment (rhTNFR:Fc) based on etanercept on a global scale. This concentration of free (unbound T0001) plasma TNFα and study was carried out to investigate the pharmacokinetics (PK) total (bound and unbound T0001) TNFα both increased sig- and immunogenicity of T0001 in healthy Chinese volunteers. nificantly after the injection http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png European Journal of Clinical Pharmacology Springer Journals

Pharmacokinetics and immunogenicity of T0001, a newly developed anti-TNFα fusion protein, in healthy volunteers

Loading next page...
 
/lp/springer_journal/pharmacokinetics-and-immunogenicity-of-t0001-a-newly-developed-anti-HjOoRYgiC0
Publisher
Springer Berlin Heidelberg
Copyright
Copyright © 2017 by Springer-Verlag GmbH Germany
Subject
Biomedicine; Pharmacology/Toxicology
ISSN
0031-6970
eISSN
1432-1041
D.O.I.
10.1007/s00228-017-2280-9
Publisher site
See Article on Publisher Site

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$49/month

Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$588

$360/year

billed annually
Start Free Trial

14-day Free Trial